Abstract:ImportanceThyroid cancer is more common in women than in men, but the associated causes of these differences are not fully understood.ObjectiveTo compare sex-specific thyroid cancer rates in the US to the prevalence of subclinical thyroid cancer at autopsy.Data SourcesData on thyroid cancer incidence and mortality by sex among US adults (≥18 years) were extracted from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program (SEER) data for 1975 to 2017. Embase, PubMed, and Web of Science databases were searched for studies on the prevalence of subclinical thyroid cancer at autopsy of men and women, from inception to May 31, 2021.Study SelectionThe Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was used to perform a systematic search for articles reporting the prevalence of subclinical thyroid cancer in autopsy results of both women and men. Of 101 studies identified, 8 studies containing 12 data sets met inclusion criteria; ie, they examined the whole thyroid gland, stated the number of thyroids examined, and reported results by sex. Excluded studies reported thyroid cancer in Japan after the atomic bombs or Chernobyl after the nuclear disaster; did not examine the whole thyroid gland or had incomplete information on thyroid examination methods; or did not report rates by sex.Data Extraction and SynthesisThyroid cancer incidence and mortality data by sex, histologic type, and tumor size were extracted from SEER. The inverse variance heterogeneity model was used to meta-analyze the prevalence and the odds ratio of subclinical thyroid cancer by sex from 8 studies (12 data sets) on thyroid cancer prevalence in autopsy results.Main Outcomes and MeasuresIncidence and mortality of thyroid cancer, by histologic type and tumor size; prevalence of thyroid cancer in autopsy results.ResultsIn 2017, 90% of thyroid cancers diagnosed were papillary thyroid cancer (PTC) and in 2013 to 2017, the women to men incidence ratio for small (≤2 cm) PTC was 4.39:1. The incidence ratio approached 1:1 as cancer type lethality increased. The ratio of thyroid cancer mortality by gender was 1.02:1 and remained stable from 1992 to 2017. Results of the meta-analysis showed that the pooled autopsy prevalence of subclinical PTC was 14% in women (95% CI, 8%-20%) and 11% in men (95% CI, 5%-18%). The pooled odds ratio of subclinical PTC in women compared with men was 1.07 (95% CI, 0.80-1.42).Conclusions and RelevanceThis cohort study and meta-analysis found that the belief that women get thyroid cancer more often than men is an oversimplification. The gender disparity is mostly confined to the detection of small subclinical PTCs, which are equally common in both sexes at autopsy but identified during life much more often in women than men. As the lethality of the cancer type increases, the ratio of detection by gender approaches 1:1. This phenomenon may be associated with gender differences in health care utilization and patterns of clinical thinking and can harm both women, who are subject to overdetection, and men, who may be at risk of underdetection.

A pooled analysis of case-control studies of thyroid cancer ¶II. Menstrual and reproductive factors

A pooled analysis of case-control studies of thyroid cancer¶ I. Methods

A Pooled Analysis of Case-Control Studies of Thyroid Cancer III. Oral Contraceptives, Menopausal Replacement Therapy and Other Female Hormones

A pooled analysis of thyroid cancer studies. V. Anthropometric factors

Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study

Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies

A Pooled Analysis of Case–control Studies of Thyroid Cancer. IV. Benign Thyroid Diseases

Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis

Case-control Study on Association of Female Reproductive Factors with Risk of Papillary Thyroid Cancer

A Pooled Analysis of Case–Control Studies of Thyroid Cancer. VI. Fish and Shellfish Consumption

A pooled analysis of case–control studies of thyroid cancer. VII. Cruciferous and other vegetables (International)

Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort

Early‐pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort

Risk factors for medullary thyroid carcinoma: a pooled analysis

Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study

A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea

Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women

Impact of Thyroid Cancer Treatment on Assisted Reproductive Technology Outcomes in Women with Infertility

Evaluation of the risk of thyroid cancer following hysterectomy through meta-analysis

Association Of Thyroid Carcinoma With Pregnancy: A Meta-Analysis

Evaluation of Gender Inequity in Thyroid Cancer Diagnosis